Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci.
Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci.
The porA gene from Neisseria meningitidis was cloned into the pRSETA vector and recombinant class 1 outer-membrane protein expressed at high levels in Escherichia coli. The protein was readily purified by affinity chromatography on a Ni2+ matrix and used for immunization of mice with conventional AI(OH)3 adjuvant, with experimental adjuvants which have the potential for human use, and with liposomes. The resulting sera were analysed for the magnitude, subclass distribution and antigenic specificity of the immune response. In addition, surface plasmon resonance (SPR) was used to quantify antibody avidity by analysis of the kinetics of binding to native class 1 protein. Immunization with conventional and experimental adjuvants induced antibodies of low avidity that did not recognize native class 1 protein. In contrast, immunization with recombinant protein in liposomes induced antibodies of high avidity which recognized native class 1 protein, as measured by their ability to label meningococcal cells in immunofluorescence assays and to inhibit the binding of a protective mAb. These properties were associated with the presence in sera of high levels of antibodies with the ability to induce complement-mediated killing of meningococci. These data show that liposomes containing recombinant class 1 protein represent a potential basis of future vaccines, of defined composition, designed for the prevention of group B meningococcal infections.
neisseria meningitidis, liposome, adjuvant, antibody avidity, vaccine
3027-3037
Christodoulides, Myron
eba99148-620c-452a-a334-c1a52ba94078
Brooks, Joy L.
b6b77058-1ffb-49a1-896a-f87b756c1420
Rattue, Elizabeth
de38f3e5-55ca-438e-a67f-4782af1ea671
Heckels, John E.
fcfcfafe-5ca8-4728-9c5e-cb67f9af7e31
November 1998
Christodoulides, Myron
eba99148-620c-452a-a334-c1a52ba94078
Brooks, Joy L.
b6b77058-1ffb-49a1-896a-f87b756c1420
Rattue, Elizabeth
de38f3e5-55ca-438e-a67f-4782af1ea671
Heckels, John E.
fcfcfafe-5ca8-4728-9c5e-cb67f9af7e31
Christodoulides, Myron, Brooks, Joy L., Rattue, Elizabeth and Heckels, John E.
(1998)
Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci.
Microbiology, 144 (11), .
(doi:10.1099/00221287-144-11-3027).
(PMID:9846738)
Abstract
The porA gene from Neisseria meningitidis was cloned into the pRSETA vector and recombinant class 1 outer-membrane protein expressed at high levels in Escherichia coli. The protein was readily purified by affinity chromatography on a Ni2+ matrix and used for immunization of mice with conventional AI(OH)3 adjuvant, with experimental adjuvants which have the potential for human use, and with liposomes. The resulting sera were analysed for the magnitude, subclass distribution and antigenic specificity of the immune response. In addition, surface plasmon resonance (SPR) was used to quantify antibody avidity by analysis of the kinetics of binding to native class 1 protein. Immunization with conventional and experimental adjuvants induced antibodies of low avidity that did not recognize native class 1 protein. In contrast, immunization with recombinant protein in liposomes induced antibodies of high avidity which recognized native class 1 protein, as measured by their ability to label meningococcal cells in immunofluorescence assays and to inhibit the binding of a protective mAb. These properties were associated with the presence in sera of high levels of antibodies with the ability to induce complement-mediated killing of meningococci. These data show that liposomes containing recombinant class 1 protein represent a potential basis of future vaccines, of defined composition, designed for the prevention of group B meningococcal infections.
This record has no associated files available for download.
More information
Published date: November 1998
Keywords:
neisseria meningitidis, liposome, adjuvant, antibody avidity, vaccine
Identifiers
Local EPrints ID: 193815
URI: http://eprints.soton.ac.uk/id/eprint/193815
ISSN: 1350-0872
PURE UUID: af0a4138-ca6a-4453-87e1-364be3143938
Catalogue record
Date deposited: 20 Jul 2011 13:43
Last modified: 15 Mar 2024 02:39
Export record
Altmetrics
Contributors
Author:
Joy L. Brooks
Author:
Elizabeth Rattue
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics